Amerisource Health Services LLC 2023-05-31 Health serious FDA
Health · FDA · Recall #FDA-D-0759-2023
Glimepiride Tablets, USP, 4 mg, RX, Packaged as a) 100-count bottle, NDC# 68001-179-00;… Recall
Issued May 31, 2023 · Amerisource Health Services LLC
In May 2023, Amerisource Health Services LLC recalled the Glimepiride Tablets, USP, 4 mg, RX, Packaged as a) 100-count bottle, NDC# 68001-179-00;…, a serious health recall reported by the FDA. Affected owners are eligible for a voluntary. Here is what the hazard is and exactly what to do about it.
Compiled by Maya Ellison, RecallCheckr
What this means for you
CGMP Deviations: recalling drug products following an FDA inspection.
What you should do
- 1 Stop using Glimepiride Tablets, USP, 4 mg, RX, Packaged as a) 100-count bottle, NDC# 68001-179-00;… right away.
- 2 Set it aside where it won't be used by mistake.
- 3 Contact Amerisource Health Services LLC to arrange your voluntary. See the official notice below for contact details.
- 4 Keep the product until your remedy is fully processed. You may need it.
Official remedy (Voluntary):
Recall details
- Brand
- Amerisource Health Services LLC
- Category
- Health
- Recall date
- May 31, 2023
- Units affected
- Not reported
- Sold at
- Nationwide USA
- Recall number
- FDA-D-0759-2023
- Made in
- United States
- Issuing agency
- FDA
In context
- Amerisource Health Services LLC has 20 recalls in our database, including 1 rated Critical.
- We're tracking 3,576 Health recalls in our database.
- This is the 903rd Health recall we've logged in 2023.